All Videos Tagged venture (MedTech I.Q.) - MedTech I.Q.

Venture:Part 1 - Mark Heesen Presentation at BioWest 2010

2010-10-17T18:09:53.129Z

COBioscience | October 09, 2010

Recorded Sept 30, 2010, at the Denver Grand Hyatt. Presenter: Mark G. Heesen, President, National Venture Capital Association.Mark Heesen has advocated for the venture capital industry, entrepreneurship and innovation for nearly two decades, first as NVCA's head of public policy and since 1999 as the Association's president. Under Mark's leadership, the NVCA has grown in both scope and scale as it relates to its public policy agenda, research initiatives, and member programs. Mark is constantly engaged in legislative and regulatory issues surrounding information technology, life sciences and clean technology investing, providing strategic direction for the NVCA professional staff and managing a board of twenty-six venture capital practitioners.

Strategy: A Model for New Life Science Ventures

2009-07-21T18:30:57.088Z

A conversation with Bob Langer and Terry McGuire at Xconomy's Life Sciences Forum.

Strategy: Bob Langer on Models of Life Science Funding

2009-07-21T18:22:56.532Z

Conversations with Bob Langer and Terry McGuire at Xconomy's Life Sciences Forum 2008

Strategy: Venture Capital Roundtable: Trends & Strategies 2009

2009-07-21T18:12:22.332Z

Speakers:
Jay Hoag, Co-founder, Technology Crossover Ventures
Reid Hoffman, Chairman and CEO, LinkedIn
Matt Murphy, Partner, Kleiner Perkins Caufield & Byers

Moderator:
Geoffrey Yang, Founding Partner, Redpoint Ventures

Navigating the venture landscape today has become quite tricky with changing company valuations, and threats such as corporate bankruptcies and limited partners reneging on their investment commitments. Given the potential landmines, as well as the new economic order, whats the outlook for the year ahead? What are the most creative and effective strategies for venture capitalists, investors and entrepreneurs? Which sectors will be profitable and which will not? Will there be a shake-out among VCs and if so, who will go and who will be left standing? Get inside the heads of some of the Valleys most respected venture capitalists and learn how they are making decisions and managing for success.

Sponsored by Cisco, Fenwick & West LLP, Silicon Valley Bank

Technology Transfer: Jo Anne Goodnight, SBIR/STTR Program Coordinator, 22 April 2009 Congressional Testimony

2009-04-24T09:09:05.365Z

Ms. Jo Anne Goodnight, National Institutes of Health, SBIR/STTR Program Coordinator, Office of Extramural Research in 22 April 2009 Congressional Hearing on the importance of small business in economic recovery.